Through proprietary advances in traditional phage display antibody library design, phage display screening and affinity maturation technologies, we rapidly generate antibodies at the required binding and specificity criteria

1. AXIOMX
CAPTURING WORLD’S PROBLEMS

2. ABOUT AXIOMX
• AxioMx is applying knowledge gained from the past 15
years of human genome sequencing to produce highly
specific recombinant antibodies against the human
proteome. The existing antibody development
paradigm is too slow and does not always result in
consistent, renewable, and quality antibodies. Through
proprietary advances in traditional phage display
antibody library design, phage display screening and
affinity maturation technologies, we rapidly generate
antibodies at the required binding and specificity
criteria. At AxioMx, we believe our platform will lead
to the wide adoption of recombinant antibody use in
research and diagnostic applications.

3. Introducing Custom Antibody Services
• AxioMx offers custom recombinant antibody discovery and
development services ranging from peptide synthesis to large-scale
antibody production.
• Our custom antibody design and development process begins by
understanding the antigen and establishing our customer's
specification requirements for each antibody. Together we
determine the desired antibody specificity, affinity, structural
modifications, labels or tags, based on the applications and sample
types with which the antibody will be used. The result is an
application-optimized antibody that works.
• The AxioMx Antibody Development Team is comprised of
proteomic and genomic experts. Together, we work with you from
design to delivery of your custom antibody. Our focus is the quality
of your experience working with us and the quality of your custom
antibody.

4. Technology Summary
• AxioMx has developed synthetic recombinant antibody
libraries, commonly known as phage display libraries,
with greater than ten billion unique clones. Diversity in
our libraries is restricted to the most variable positions
in the complementarity determining regions (CDRs) of
natural antibody sequences. Our antibody frameworks
have been optimized for protein expression, and our
libraries efficiently generate binders to peptides as
well as protein antigens.
• We utilize a "rapid liquid approach" in our
automated phage display screening methodology to
select for antibodies with both high affinity and high
specificity.

5. A Complete Services Offering. From
Peptides to Production.
• Our range of services include phage display
library development and screening services,
epitope mapping, affinity maturation,
antibody structural modification, and antibody
production.

7. CONTACT US
• AxioMx, Inc.
688 East Main Street
Branford, CT 06405
• Main: 203-208-1918
Fax: 203-433-4068
• Directions:
• Take I-95 to exit 55 for US-1 / East Main Street
toward North Branford
Turn right onto US-1 / East Main Street
Travel 1.7 miles on US-1 / East Main Street to 688
E. Main Street